Pages that link to "Q39997902"
Jump to navigation
Jump to search
The following pages link to Analyzing antibody-Fc-receptor interactions (Q39997902):
Displaying 35 items.
- Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo (Q24568302) (← links)
- FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA (Q24628070) (← links)
- Metastatic melanomas express inhibitory low affinity fc gamma receptor and escape humoral immunity (Q34002125) (← links)
- An in vitro model of antibody-enhanced killing of the intracellular parasite Leishmania amazonensis (Q34142338) (← links)
- An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum (Q35077677) (← links)
- Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants (Q35866472) (← links)
- Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer (Q36339643) (← links)
- Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1. (Q36380184) (← links)
- Circulating antibodies and macrophages as modulators of adenovirus pharmacology (Q36759761) (← links)
- Serum amyloid P inhibits granulocyte adhesion (Q36770572) (← links)
- SHIP limits immunoregulatory capacity in the T-cell compartment. (Q37143643) (← links)
- The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria (Q37239883) (← links)
- Analysis of the Fc gamma receptor-dependent component of neutralization measured by anthrax toxin neutralization assays (Q37374655) (← links)
- Respiratory syncytial virus persistence in macrophages upregulates Fcgamma receptors expression (Q37611827) (← links)
- Current and Potential Uses of Immunocytokines as Cancer Immunotherapy (Q37637949) (← links)
- Progressive changes in composition of lymphocytes in lung tissues from patients with non-small-cell lung cancer (Q37687671) (← links)
- Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy (Q37725351) (← links)
- The humoral response to HIV-1: new insights, renewed focus. (Q37789346) (← links)
- The role of sialic acid as a modulator of the anti-inflammatory activity of IgG. (Q37995919) (← links)
- B cells and their mediators as targets for therapy in solid tumors (Q38090232) (← links)
- Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions (Q38748910) (← links)
- S100A8 causes a shift toward expression of activatory Fcγ receptors on macrophages via toll-like receptor 4 and regulates Fcγ receptor expression in synovium during chronic experimental arthritis. (Q39675307) (← links)
- Characterization of the antifungal functions of a WGA-Fc (IgG2a) fusion protein binding to cell wall chitin oligomers (Q41842506) (← links)
- Highly parallel characterization of IgG Fc binding interactions. (Q42909129) (← links)
- A Novel System for the Quantification of the ADCC Activity of Therapeutic Antibodies (Q47107003) (← links)
- Prospects from systems serology research (Q47346211) (← links)
- FCGR Polymorphisms Influence Response to IL2 in Metastatic Renal Cell Carcinoma. (Q52839874) (← links)
- Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein. (Q53078816) (← links)
- Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival (Q55055409) (← links)
- Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches (Q57795000) (← links)
- Antiviral Functions of Monoclonal Antibodies against Chikungunya Virus (Q66680697) (← links)
- Ligation of porcine Fc gamma receptor I inhibits levels of antiviral cytokine in response to PRRSV infection in vitro (Q86248748) (← links)
- Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools (Q89993478) (← links)
- Functional, Biophysical, and Structural Characterization of Human IgG1 and IgG4 Fc Variants with Ablated Immune Functionality (Q90241506) (← links)
- Antibody-drug conjugates: smart weapons against cancer (Q99630424) (← links)